Recruiting
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
NCT04915248
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
- Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Milan, Italy
- U.O. Ematologia AO di Padova Padova, Italy
- Ematologia IRCCS Policlinico S. Matteo di Pavia Pavia, Italy